insulin glulisine

Insulin glulisine, also known by its brand name Apidra, is a rapid-acting insulin used to control blood sugar levels in people with diabetes. It is a synthetic form of human insulin that works by replacing the insulin that the body would normally produce.

It is typically injected just under the skin, either through a syringe or an insulin pump. One of the key advantages of insulin glulisine is its fast onset of action. It starts working within 10-15 minutes after injection, making it a suitable option for managing post-meal blood sugar spikes. Its rapid action helps to mimic the body’s natural insulin response, allowing for better control of blood sugar levels.